BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 23555021)

  • 21. Human Wharton's jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy.
    La Rocca G; Lo Iacono M; Corsello T; Corrao S; Farina F; Anzalone R
    Curr Stem Cell Res Ther; 2013 Jan; 8(1):100-13. PubMed ID: 23317435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative separation methods and biological characteristics of human placental and umbilical cord mesenchymal stem cells in serum-free culture conditions.
    Yi X; Chen F; Liu F; Peng Q; Li Y; Li S; Du J; Gao Y; Wang Y
    Stem Cell Res Ther; 2020 May; 11(1):183. PubMed ID: 32430063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells from Patients with Amyotrophic Lateral Sclerosis and Healthy Donors.
    Javorkova E; Matejckova N; Zajicova A; Hermankova B; Hajkova M; Bohacova P; Kossl J; Krulova M; Holan V
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):215-225. PubMed ID: 30242613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta.
    Du WJ; Chi Y; Yang ZX; Li ZJ; Cui JJ; Song BQ; Li X; Yang SG; Han ZB; Han ZC
    Stem Cell Res Ther; 2016 Nov; 7(1):163. PubMed ID: 27832825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions.
    Thirlwell KL; Colligan D; Mountford JC; Samuel K; Bailey L; Cuesta-Gomez N; Hewit KD; Kelly CJ; West CC; McGowan NWA; Casey JJ; Graham GJ; Turner ML; Forbes S; Campbell JDM
    Cytotherapy; 2020 Dec; 22(12):762-771. PubMed ID: 32828673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Explants-isolated human placenta and umbilical cord cells share characteristics of both epithelial and mesenchymal stem cells.
    Anastasiu DM; Cean A; Bojin MF; Gluhovschi A; Panaitescu C; Păunescu V; Tănăsie G
    Rom J Morphol Embryol; 2016; 57(2):383-90. PubMed ID: 27516009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue.
    Heo JS; Choi Y; Kim HS; Kim HO
    Int J Mol Med; 2016 Jan; 37(1):115-25. PubMed ID: 26719857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VCAM-1+ placenta chorionic villi-derived mesenchymal stem cells display potent pro-angiogenic activity.
    Du W; Li X; Chi Y; Ma F; Li Z; Yang S; Song B; Cui J; Ma T; Li J; Tian J; Yang Z; Feng X; Chen F; Lu S; Liang L; Han ZB; Han ZC
    Stem Cell Res Ther; 2016 Apr; 7():49. PubMed ID: 27044487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells.
    Panepucci RA; Siufi JL; Silva WA; Proto-Siquiera R; Neder L; Orellana M; Rocha V; Covas DT; Zago MA
    Stem Cells; 2004; 22(7):1263-78. PubMed ID: 15579645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulatory properties of bone marrow mesenchymal stem cells.
    Mohanty A; Polisetti N; Vemuganti GK
    J Biosci; 2020; 45():. PubMed ID: 32713861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative investigation of the differentiation capability of bone-marrow- and adipose-derived mesenchymal stem cells by qualitative and quantitative analysis.
    Vishnubalaji R; Al-Nbaheen M; Kadalmani B; Aldahmash A; Ramesh T
    Cell Tissue Res; 2012 Feb; 347(2):419-27. PubMed ID: 22287041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
    Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of human mesenchymal stem cells derived from dental pulp, bone marrow, adipose tissue, and umbilical cord tissue by gene expression.
    Stanko P; Kaiserova K; Altanerova V; Altaner C
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):373-7. PubMed ID: 24145770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord.
    Thaweesapphithak S; Tantrawatpan C; Kheolamai P; Tantikanlayaporn D; Roytrakul S; Manochantr S
    Stem Cell Res Ther; 2019 Mar; 10(1):79. PubMed ID: 30845980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and Characterization of Human Umbilical Cord-derived Mesenchymal Stem Cells from Preterm and Term Infants.
    Iwatani S; Yoshida M; Yamana K; Kurokawa D; Kuroda J; Thwin KKM; Uemura S; Takafuji S; Nino N; Koda T; Mizobuchi M; Nishiyama M; Fujioka K; Nagase H; Morioka I; Iijima K; Nishimura N
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30741254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic analysis of porcine mesenchymal stem cells derived from bone marrow and umbilical cord: implication of the proteins involved in the higher migration capability of bone marrow mesenchymal stem cells.
    Huang L; Niu C; Willard B; Zhao W; Liu L; He W; Wu T; Yang S; Feng S; Mu Y; Zheng L; Li K
    Stem Cell Res Ther; 2015 Apr; 6(1):77. PubMed ID: 25889491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neural ganglioside GD2 identifies a subpopulation of mesenchymal stem cells in umbilical cord.
    Xu J; Liao W; Gu D; Liang L; Liu M; Du W; Liu P; Zhang L; Lu S; Dong C; Zhou B; Han Z
    Cell Physiol Biochem; 2009; 23(4-6):415-24. PubMed ID: 19471109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive characterisation of large-scale expanded human bone marrow and umbilical cord mesenchymal stem cells.
    Mennan C; Garcia J; Roberts S; Hulme C; Wright K
    Stem Cell Res Ther; 2019 Mar; 10(1):99. PubMed ID: 30885254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.